Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization

MORRISVILLE, N.C. and NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH) and Aetion® announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve patient outcomes. The partnership brings together Syneos Health’s proprietary data collection and research solutions with Aetion Evidence Platform® (AEP) to generate evidence through patient data curation and real-world data.

Read the source article at Send Press Releases with GlobeNewswire
2021-08-02 13:20:09